Filter
370
Text search:
International
Pharmaceutical
Federation
Featured
Recommendations
35
New Publications
84
Language
Document type
No document type
189
Studies & Reports
76
Guidelines
54
Manuals
19
Strategic & Response Plan
16
Training Material
9
Fact sheets
3
Situation Updates
2
Resource Platforms
2
Countries / Regions
Global
24
Nigeria
16
India
16
Western and Central Europe
13
Ukraine
11
Kenya
8
South Africa
8
Eastern Europe
6
Sierra Leone
4
Ethiopia
4
Eastern Europe and Central Asia
4
Africa
4
Russia
4
Liberia
3
Uganda
3
Syria
3
Asia
3
Senegal
2
Cameroon
2
Zimbabwe
2
Philippines
2
Nepal
2
Tanzania
2
Rwanda
2
Brazil
2
Lesotho
2
Myanmar / Burma
2
Latin America and the Carribbean
2
Moldova
2
Kyrgyzstan
2
Guinea
1
Congo, Democratic Republic of
1
Mali
1
Ghana
1
Niger
1
South Sudan
1
Iraq
1
Jordan
1
Germany
1
Chad
1
Bangladesh
1
Namibia
1
North Macedonia
1
Serbia
1
Botswana
1
Venezuela
1
Albania
1
Armenia
1
Laos
1
Tajikistan
1
Bulgaria
1
Uzbekistan
1
Kazakhstan
1
Georgia
1
Turkmenistan
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
92
Clinical Guidelines
35
Key Resources
25
Public Health
21
Women & Child Health
11
Pharmacy & Technologies
8
Capacity Building
7
Toolboxes
Pharmacy
33
Mental Health
32
HIV
30
TB
30
AMR
28
COVID-19
23
NCDs
20
Conflict
14
Rapid Response
12
Global Health Education
9
Planetary Health
8
Caregiver
7
Ebola & Marburg
5
Refugee
5
Specific Hazards
4
NTDs
4
Health Financing Toolbox
3
2.0 Rapid Response
3
Disability
2
Polio
2
Natural Hazards
2
Zika
1
World Drug Report 2017
-1-
Accessed: 14.03.2019
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a
...
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul
...
First report of a demonstration project
The WHO document "Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance" provides a framework for integrating noncommunicable diseases (NCDs) into existing health programs for HIV/AIDS, tub
...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kyrgyzstan. This report provides evidence through three analyses that NCDs reduce economic outp
...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding
...
Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance
Strengthening health-system emergency preparedness.
This report presents an overview of the transition process in Azerbaijan, some sustainability aspects and challenges stemming from donor withdrawal from TB-related activities, along with recommendations on how to overcome transition-related difficulties and ensure sustainability.
The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessment made by an external group of experts convened as members of the Guideline Development Group. Moreover, these guidelines focus on interventions speci
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
These guidelines provide specific recommendations and expert suggestions — for national policy-makers and programme managers and their partners and stakeholders— on prioritizing, planning and providing HIV testing, counselling, treatment and care services for adolescents
Opiates, cocaine, cannabis
World Drug Report 2017
-3-
Accessed: 14.03.2019
